Polyprenols (Ropren) in Acute Coronary Syndrome

• Status: Completed
• Trial end date: 2018-02-28
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to determine efficacy and safety of polyprenols (ROPREN) using in patients with acute coronary syndrome

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences

Criteria

Inclusion Criteria:

• Acute coronary syndrome

• Informed consent received

Exclusion Criteria:

• Patient's incapacity to take accurately drops by oneself

• Cardiogenic shock